McNeill Jonathan bought CBIO
December 8, 2025 · Form 4 insider transaction
McNeill Jonathan bought 172,836 shares of Crescent Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
172,836
Price
$0.00
Total value
N/A
InsiderMcNeill Jonathan
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateDecember 8, 2025
Filing dateDecember 10, 2025
Shares owned after172,836
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase shares of the Issuer's ordinary shares and vests in 48 approximately equal monthly installments that commenced on December 8, 2025.